MARIO
DELGADO MORA
Researcher to 2008
Publications (149) MARIO DELGADO MORA publications
2022
-
Editorial: The innate immune system in rheumatoid arthritis
Frontiers in Immunology
2019
2014
-
Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease
Haematologica, Vol. 99, Núm. 7, pp. 1168-1175
2012
-
NPSR1 gene is associated with reduced risk of rheumatoid arthritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1166-1170
2009
-
Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses
Gastroenterology, Vol. 136, Núm. 3, pp. 978-989
-
Generating tolerogenic dendritic cells with neuropeptides
Human Immunology, Vol. 70, Núm. 5, pp. 300-307
-
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
Gut, Vol. 58, Núm. 7, pp. 929-939
-
Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death
Cell Death and Differentiation, Vol. 16, Núm. 3, pp. 406-416
-
Requirement of IFN-γ-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells
Tissue Engineering - Part A, Vol. 15, Núm. 10, pp. 2795-2806
-
Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells
Arthritis and Rheumatism, Vol. 60, Núm. 4, pp. 1006-1019
2008
-
Anti-inflammatory neuropeptides: A new class of endogenous immunoregulatory agents
Brain, Behavior, and Immunity, Vol. 22, Núm. 8, pp. 1146-1151
-
Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders
Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2, pp. 135-140
-
Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: A new therapeutic approach for immune disorders
Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 5B, pp. 1830-1847
-
Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells
Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1010-1019
-
Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria
Journal of Immunology, Vol. 180, Núm. 12, pp. 8369-8377
-
Immunotherapy for neurological diseases
Clinical Immunology
-
In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis
Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1026-1037
-
Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells
Annals of the Rheumatic Diseases, Vol. 67, Núm. 9, pp. 1235-1241
-
N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: Randomized, placebo-controlled pilot study
World Journal of Gastroenterology, Vol. 14, Núm. 18, pp. 2851-2857
-
Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1
American Journal of Pathology, Vol. 172, Núm. 5, pp. 1297-1302